Dermapharm Holding Se · XETR:DMP
Dermapharm — Investor Day (2022)
35 slides from Dermapharm's investor day presentation, 2022
Slide 1: Euromed – Xavier Roig, CEO
3 Euromed – Xavier Roig, CEO
Slide 2: At a glance
3.1 Ataglance | aa I) || aa
Slide 3: Our history: how we started…
Our history: how we started… … and what we do now? Milk thistle extract Phyto-pharma: Drying facility for Acquisition of Probelte launched European expansion saw palmetto, Florida Biotechnolgies, Murcia Germany France Switzerland 1960 1973 2006 2017 1919 1971 1996 2018 Madaus founded in Euromed foun
Slide 4: Who we are…
Who we are… … and our future perspective? Leading producer of herbal extracts and natural active ingredients mainly for the phyto-pharma and dietary supplements market Mollet del Vallès Mollet Innovation Center Murcia (water-based extraction) Florida (drying facility) Today Our Strategy Our Vision R
Slide 5: Euromed worldwide serving 400+ customers
Euromed worldwide serving 400+ customers in 50 countries Own people Agents Milk Thistle extract launched Capital Markets Day 2022 5
Slide 6: Products
3.2 Products Image: Looker_Studio / Adobe Stock
Slide 7: Sources for herbal extracts
Sources for herbal extracts Cultivated plants Wild plants Breeding Genotype Origins Sourcing GACP1 1 GACP - Good Agricultural and Collection Practices Milk Thistle extract launchedCapital Markets Day 2022 7
Slide 8: Broad product portfolio of herbal extracts…
Broad product portfolio of herbal extracts… Artichoke Ashwagandha Bearberry Billberry Bladderwrack Devil’s Claw Echinacea ang. Escin Fig fruit Garlic Ginkgo Biloba Ginseng Grape Seed Hawthorn Hop Strobile Horse Chestnut Kava Kava Magnolia Matricaria Melissa Milk Thistle Nettle Olive Passionflower Pi
Slide 9: … with global leadership in eight extracts
… with global leadership in eight extracts generating 80% of revenues with 95 SKU’s Our USP First supplier for originator Bladderwrack in pharma Artichoke Ashwagandha Bearberry Billberry Devil’s Claw Echinacea ang. Escin Complete traceability State of the art facilities Fig fruit Clinically Garlic p
Slide 10: Mediterranean fruit and vegetable extracts
Such as our mediterranean fruit and vegetable extracts based on water extraction facilities in Murcia Milk Thistle extract launched Capital Markets Day 2022 10
Slide 11: ABAlife – a fig fruit extract
ABAlife ® – a fig fruit extract to support a healthy carbohydrate metabolism and glycemic index of foods Prevalence diabetes: Further 84m US people 37.3m Americans1 have prediabetes1 Product patent Process patent Exclusive license Proven efficacy… confirmed in scientific articles… supported by Ameri
Slide 12: Pomanox – a pomegranate extract
Pomanox® – a pomegranate extract to reduce blood pressure 47% of Americans (116m) Pomanox® contains active compounds present in the fruit and many have high blood pressure1 beneficial properties and antioxidant capacity come from punicalagins Proven efficacy… … confirmed by research Current status:
Slide 13: Mediteanox – an olive fruit extract
Mediteanox® – an olive fruit extract is beneficial for cardiovascular support and healthy aging Blood lipids from …can be reduced by Mediteanox® to lower oxLDL-cholesterol in plasma oxidative stress… Proven efficacy… … supported by Milk Thistle extract launched Capital Markets Day 2022 13
Slide 14: Scientifically proven premium extracts
Scientifically proven premium extracts with a transparent, traceable and sustainable process Milk Thistle extract launched Capital Markets Day 2022 14
Slide 15: Market environment
3.2 Market environment Image: Euromed
Slide 16: Staying healthier
Staying healthier More exercise Better nutrition More prevention More natural Milk Thistle extract launched Capital Markets Day 2022 16
Slide 17: Getting older: life expectancy
Getting older Life expectancy US In 1971 72 Now 79 Germany 71 81 Australia 71 83 Spain 72 83 Japan 73 86 Milk Thistle extract launched Capital Markets Day 2022 17
Slide 18: Getting older: life expectancy and extracts
Getting older Life expectancy Saw Palmetto Milk Thistle Horse Chestnut Urinary Liver Circulatory Milk Thistle extract launched Capital Markets Day 2022 18
Slide 19: Plant extracts market serves a market volume of >€25bn
Plant extracts market serves a market volume of >€25bn1 USA and APAC are expected to be the fastest-growing regions2 Global market volume Key market dynamics €bn CAGR +8.5% 25.3 35.1 Phyto-pharma 25.3 Increase suitable from allopathic medicine to natural products Quality control and registration
Slide 20: Phyto-pharma products with long regulatory process
Phyto-pharma products with long and cumbersome regulatory process Long product life Barriers to switch Long relationships High cost Phyto- Several pharma years 55% Milk Thistle extract launched Capital Markets Day 2022 20
Slide 21: Competitive landscape: Phyto-pharma products
Competitive landscape: Phyto-pharma products with limited number of competitors Botanical High Pharma Fast sales Innovation experience quality applications growth Capital Markets Day 2022 21
Slide 22: Dietary supplements with more regulation to come
Dietary supplements with more regulation to come 76% of US adults take dietary supplements Dietary supplements 43% of Americans use the internet to 70% get health information Large market Annual growth rate of online sales 20% Consumer awareness of dietary supplements in the US Fast growing Milk Thi
Slide 23: Competitive landscape: Dietary supplements / functional foods
Competitive landscape: Dietary supplements / functional foods with huge number of competitors but limited in high quality Revenue Field Food & Beverages, Natural Naturex part of Giuvadan (FR) €400m Health, Personal Care Food & Beverages, Natural Frutarom part of IFF (USA) €100m Health, Personal Care
Slide 24: Operations
3.4 Operations Image: Euromed
Slide 25: Euromed manufacturing sites
Euromed manufacturing sites How we produce? Innovation Center Mollet del Vallès Capacities More efficient 2018 4,200t 2023 4,500t Phyto-pharma Full Capacity 4,500t Solvents Capacities More green Drying facility Murcia Florida 2018 200t for Dietary saw palmetto 2023 4,500t supplement Full Capacity >4
Slide 26: Euromed certifications
Euromed certifications Capital Markets Day 2022 26
Slide 27: ESG
ESG Eco-friendly waste management Composting Animal feed Textiles EARTH COLORS BY Capital Markets Day 2022 27
Slide 28: ESG - Sustainability
ESG - Sustainability supported by different initiatives BEST PROJECT “Best Project Initiative” invited employees to submit sustainable project ideas. Winner project: installation of photovoltaic panels CARBON FOOTPRINT LAUNCH OF VIRTUAL Different projects and SOLIDARITY RACE initiatives to reduce Eu
Slide 29: Financials
3.5 Financials Image: Euromed
Slide 30: Challenging market environment
Challenging market environment in recent years Growth COVID-19 pandemic Inflation Stable Energy & RM Double-digit growth (+10%) Slow down in pharma (EU) & growth in dietary supplements (USA & Asia) price increase Business Business as usual Business transformation adaptability 2015 2016 2017 2018 201
Slide 31: Stable revenue development
Stable revenue development despite COVID-19 pandemic Total Revenue1 Actual Plan Main future growth drivers €m 72 72 72 Double digit growth in USA & Asia Launch of new products Med extracts consolidation New customer-made projects 2019 2020 2021 2022e Adj. EBITDA1 €m Strong raw materials an
Slide 32: Revenue growth
Revenue growth driven by further diversification by region by specie by client Asia 25% Saw Palmetto Client 1 40% 77% 2022 USA 35% Milk Thistle 18% Client 2 10% 50% EMEA 40% 5% Rest Rest Asia Saw Palmetto Client 1 18% 28% 41% 2018 26% 69% USA Milk Thistle 20% Client 2 62% 5% EMEA 31% Rest Rest Capit
Slide 33: Key success factors…
Key success factors… … or secret formula Favourable regulation trends Global commercial platform Sourcing & traceability State of the art facilities Clinically proven & innovation Analytical & production know-how Milk Thistle extract launched Capital Markets Day 2022 33
Slide 34: Disclaimer
Disclaimer This publication includes statements, estimates, opinions and projections with respect to the anticipated future performance of Dermapharm Holding SE (together with its consolidated subsidiaries, “Dermapharm”) and such statements, estimates, opinions and projections (“Forward-Looking Stat
Slide 35: For information, please contact
For information, please contact Britta Hamberger Investor Relations & Corporate Communications Dermapharm Holding SE E-Mail: ir@dermapharm.com Phone: +49 (0) 89 641 86 233 Dermapharm FY 2021 35